The MR analysis demonstrated that GLP-1 RAs may reduce the risk of mood disorder-related ADRs, including anxiety, depression, bipolar disorder, emotionally unstable personality disorder, and suicide. This evidence concerns the gene GLP1R and depressive symptom measurement.